Latest Articles

Publication Date
Is Lufax Holding Ltd (0VU1) stock a top pick for value investors - 2025 Dividend Review & AI Forecasted Entry and Exit Points - ulpravda.ru

Is Lufax Holding Ltd (0VU1) stock a top pick for value investors - 2025 Dividend Review & AI Forecasted Entry and Exit Points ulpravda.ru

Published: Dec. 20, 2025, 5:43 p.m.
Why OrthoPediatrics Corp. stock appeals to dividend seekers - Market Risk Analysis & AI Based Buy and Sell Signals - ulpravda.ru

Why OrthoPediatrics Corp. stock appeals to dividend seekers - Market Risk Analysis & AI Based Buy and Sell Signals ulpravda.ru

Published: Dec. 20, 2025, 10:57 a.m.
Bayer expands access to endometriosis treatment - The Express Tribune

Bayer expands access to endometriosis treatment The Express Tribune

Published: Dec. 20, 2025, 9:33 a.m.
Bayer Pakistan continues its women’s health focus by launching new medication to treat endometriosis - The Express Tribune

Bayer Pakistan continues its women’s health focus by launching new medication to treat endometriosis The Express Tribune

Published: Dec. 20, 2025, 9:32 a.m.
Dysmenorrhoea presentation in Herlyn-Werner-Wunderlich syndrome: A case study.

Herlyn-Werner-Wunderlich syndrome is a rare congenital anomaly characterized by uterus didelphys, obstructed hemi-vagina, and ipsilateral renal agenesis. This study aims to present a case of Herlyn-Werner-Wunderlich syndrome seen at Shifa …

Published: Dec. 20, 2025, midnight
Pharmacokinetic-Pharmacodynamic Modeling and Simulation of Merigolix, a Nonpeptide Gonadotropin-Releasing Hormone Antagonist.

Gonadotropin-releasing hormone (GnRH) antagonists inhibit estrogen synthesis and secretion, making them promising treatment options for estrogen-dependent diseases, such as endometriosis. This study developed a population pharmacokinetic/pharmacodynamic (PK/PD) model for merigolix, …

Published: Dec. 20, 2025, midnight
Copper Intrauterine Device Migration Into Cesarean Scar Niches Without Complications: A Case Report.

Intrauterine devices (IUDs), both hormonal and nonhormonal, are widely used contraceptive methods, with approximately 20% of reproductive-aged women worldwide utilizing them. Although IUDs are generally considered safe and effective, complications …

Published: Dec. 20, 2025, midnight
Non-Invasive Diagnosis of Endometriosis by Questionnaires in Patients Using Contraception.

Background/Objectives: The assessment of endometriosis (EMS)-associated pain is important, but only very few studies address the potential use of questionnaires for non-invasive prediction of the disease. Methods: In a prospective …

Published: Dec. 20, 2025, midnight
Ultrasound-guided microwave ablation for the treatment of abdominal wall scar endometriosis.

To evaluate the efficacy of ultrasound (US)-guided microwave ablation (MWA) in treating abdominal wall endometriosis (AWE) lesions located at the cesarean scar and to assess the early clinical outcomes of …

Published: Dec. 20, 2025, midnight
How cyclical is Blueprint Medicines Corporation (2L9) stock compared to rivals - July 2025 Gainers & Safe Entry Momentum Stock Tips - Улправда

How cyclical is Blueprint Medicines Corporation (2L9) stock compared to rivals - July 2025 Gainers & Safe Entry Momentum Stock Tips Улправда

Published: Dec. 19, 2025, 10:41 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!